Lexpos News

/Lexpos News

Pharmacy First myth busting series (#4)

This is the fourth of a series of articles to tackle some of the misconceptions around Pharmacy First. The articles will cover a variety of aspects of Pharmacy First and aims to myth bust, to increase understanding of the service. Patients with only certain minor illnesses can be electronically referred for the minor illness strand [...]

The post Pharmacy First myth busting series (#4) appeared first on Community Pharmacy England.

By |August 21st, 2024|Lexpos News|Comments Off on Pharmacy First myth busting series (#4)

MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

Class 4 Medicines Defect Information: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Drug alert number: EL (24)A/39 Date issued: 19 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Company name: Glenmark Pharmaceuticals Europe [...]

The post MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

By |August 19th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

Pharmacy First myth busting series (#3)

This is the third of a series of articles to tackle some of the misconceptions around Pharmacy First. The articles will cover a variety of aspects of Pharmacy First and aims to myth bust, to increase understanding of the service. Patients who are electronically referred who have symptoms of a more serious illness/red flags should [...]

The post Pharmacy First myth busting series (#3) appeared first on Community Pharmacy England.

By |August 19th, 2024|Lexpos News|Comments Off on Pharmacy First myth busting series (#3)

Morning after pill services at risk as pharmacies close and make cuts

iNews Women’s health experts have raised concerns over reports more pharmacies will shut or stop providing emergency contraception. This comes after research by Community Pharmacy England showed 96% of pharmacy owners said they had to stop providing locally commissioned services in the past 12 months. It also follows recent analysis by the National Pharmacy Association [...]

The post Morning after pill services at risk as pharmacies close and make cuts appeared first on Community Pharmacy England.

By |August 18th, 2024|Lexpos News|Comments Off on Morning after pill services at risk as pharmacies close and make cuts

August 2024 Price Concessions 1st Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/08/2024) announced the following list of price concessions for August 2024: Drug Pack size Price concession Amiloride 5mg tablets 28 £15.70 Amisulpride 200mg tablets 60 £28.42 Bimatoprost 300micrograms/ml / [...]

The post August 2024 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |August 16th, 2024|Lexpos News|Comments Off on August 2024 Price Concessions 1st Update